Nanopharmasolutions, Inc

Nano PharmaSolutions (NPS) has developed the platform nanodrug delivery technology, NanoTransformer® that generates nanoparticles of small molecule drugs without using lipids or polymers. NanoTransformer is the only drug nanoparticle generation process that uses phase-transition technology to enhance the solubility of BCS 2 and BCS 4 APIs without the use of excipients. The cGMP manufacturing facility opens in 2024. Nano PharmaSolutions delivers CNS therapeutics through nose to bring delivery using NanoTransformer process. This clean nanotechnology can safely and effectively deliver drugs to brain through the nose because it doesn't contain other chemicals for nanoengineering.